
Emsilac 150mg Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Lacosamide (150mg)
Overview Emsilac 150mg Tablet
Epileptic seizures are managed and prevented with the anticonvulsant, Emsilac 150mg tablets. These tablets reduce excessive brain nerve cell activity, thus controlling seizures. Emsilac 150mg can be taken with or without food, ideally at the same time daily. Missed doses should be taken immediately upon recall; discontinuing treatment can be dangerous, necessitating a readily available supply. Complete the prescribed course, even with improvement, and consult your physician before cessation, as this can trigger increased seizure activity. Pre-existing heart conditions should be disclosed to your doctor prior to commencing treatment. Potential side effects include headaches, dizziness, dry mouth, muscle stiffness, vision disturbances (including blurred or double vision), nausea. These are generally temporary and resolve spontaneously. Weight gain is a possible side effect; maintaining a healthy diet and exercise routine can help mitigate this.
Uses of Emsilac 150mg Tablet
Convulsive disorders
Major Benefits of Emsilac 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Emsilac 150mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Emsilac 150mg Tablet:
- Dizziness
- Headache
- Nausea
- Sleepiness
- Vomiting
- Visual disturbance
- Dryness in mouth
- Muscle spasm
How to use Emsilac 150mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Emsilac 150mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Emsilac 150mg Tablet works:
Emsilac 150mg tablets function as an anticonvulsant, gradually reducing the responsiveness of neuronal sodium channels. This mechanism diminishes hyperactivity within the brain's neural network, effectively managing seizures.
SAFETY ADVICE
AlcoholCAUTION
Use of Emsilac 150mg Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Emsilac 150mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Emsilac 150mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 150mg Emsilac tablet can lead to drowsiness, reduced alertness, and visual disturbances. Driving should be avoided if these side effects manifest. Dizziness and blurred vision are potential effects of Emsilac 150mg tablets, potentially impairing driving ability.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Emsilac 150mg tablets requires careful consideration. Dosage modification of Emsilac 150mg tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Emsilac 150mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Emsilac 150mg tablets; consult a physician for guidance.
What if you forget to take Emsilac 150mg Tablet :
Should you forget to take your Emsilac 150mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Emsilac 150mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Antiepileptic drugs targeting sodium channels |
